65LAB
Singapore, Singapore · Founded 2023
- Headquarters
- Singapore
- Founded
- 2023
- Business Model
- B2B
- Last Round
- Corporate Round
- Rounds
- 1
About
65LAB was founded to turn innovations into lifesaving medicines, with a mission to drive scientific advancement and create new therapeutic companies from Singapore. The venture-creation platform accelerates the drug discovery pathway by bringing together leading Singapore research institutions, established life-science investors, and drug discovery partner Evotec SE. The name pays homage to the year Singapore became an independent nation and to the country's dialing code.
Summary
65LAB is a Biotech company based in Singapore, Singapore, founded in 2023. Investors include ClavystBio, Leaps by Bayer and Polaris Partners.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.